Schering creates new role for Jorn
Schering-Plough has appointed Deborah Jorn a group vice president, global allergy/respiratory marketing, primary care customer group, a new position. Jorn joins from Johnson & Johnson, where she was worldwide vice president, internal medicine, early commercial input and emerging franchises. She previously worked at Pharmacia, where she was global vice president for Detrol/Detrusitol and urology.
She reports to Ellen Geisel, senior vice president, primary care customer group, and is responsible for the company's global allergy and respiratory franchise, including Nasonex and Clarinex.